Prostate Specific Antigen (PSA), the normal range of which is 0-4ng/ml, is indicative of Benign Prostatic Hyperplasia (BPH), Prostatitis (PSA) or Prostatic Cancer (PC) when there is an enlarged prostate and PSA is elevated up to 11μg/L. The diagnosis should be made in conjunction with further investigations.
It is necessary to combine with further examination to clarify the diagnosis, and choose the corresponding treatment according to the cause of the disease, such as observation and waiting, medication, surgery and so on.
1. Benign prostatic hyperplasia: according to the condition, follow up, medication such as terazosin and finasteride, etc., and surgical treatment such as urethral resection of the prostate and transurethral enucleation of the prostate.
2. Prostatitis: Some patients with prostatitis may also have enlarged prostate with elevated PSA, which can be clearly diagnosed with further examination such as prostate fluid examination, and anti-infective drugs such as erythromycin and doxycycline can be given according to the situation.
3. Prostate cancer: It can be further diagnosed by combining with other examination results such as prostate puncture pathology biopsy, etc. If the diagnosis is confirmed, according to the patient’s condition, surgical treatment (radical prostatectomy), chemotherapy (docetaxel), radiotherapy, endocrine therapy (goserelin, abiraterone), etc. can be chosen.
It is recommended that patients with enlarged prostate with PSA elevated up to 11μg/L should consult a doctor in time, under the guidance of the doctor and with the results of further examination to clarify the diagnosis and target treatment.